Trial Profile
Phase I trial investigating the pharmacokinetics and tolerability of delafloxacin after multiple dosing (5 days)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Respiratory tract infections; Skin infections; Soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 05 Nov 2010 New trial record.